Last 12 months
Inside the activity.
0 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 5 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 04, 2016 Filed Oct 6, 2016 17:27 UTC |
Lenggenhager RenePresident, BioSpin Group
|
GrantCommon Stock | 5,634 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-16-030519 · edgar.xml · nonDerivative · entry 1 Lenggenhager Rene · CIK 0001658018 · President, BioSpin Group 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,037 F1 · shares: Shares are represented by restricted stock units. Shares of restricted common stock vest in four approximately equal annual installments on the anniversary of the grant date, commencing October 4, 2017. Read SEC document |
| October 04, 2016 Filed Oct 6, 2016 17:27 UTC |
Knell Michael GunnarChief Accounting Officer
|
GrantStock Option (Right to Buy) · Derivative | 5,856 | $0.00 Strike: $22.19 | $0.00 |
DisclosureSEC source: 0001179110-16-030517 · edgar.xml · derivative · entry 2 Knell Michael Gunnar · CIK 0001543779 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,856 Underlying: Common Stock · 5,856 shares Expires 2026-10-04 F2 · derivative.exercise_date: The option vests in four approximately equal annual installments on the anniversary of the grant date, commencing October 4, 2017. Read SEC document |
| October 04, 2016 Filed Oct 6, 2016 17:27 UTC |
Knell Michael GunnarChief Accounting Officer
|
GrantCommon Stock | 1,839 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-16-030517 · edgar.xml · nonDerivative · entry 1 Knell Michael Gunnar · CIK 0001543779 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,839 F1 · shares: Shares are represented by restricted stock units. Shares of restricted common stock vest in four approximately equal annual installments on the anniversary of the grant date, commencing October 4, 2017. Read SEC document |
| September 20, 2016 Filed Jan 9, 2017 21:00 UTC |
PACKER RICHARD ADirector
|
OtherCommon Stock | 50.92 | $22.04 | $1,122.28 |
DisclosureSEC source: 0001179110-17-000745 · edgar.xml · nonDerivative · entry 3 PACKER RICHARD A · CIK 0001237765 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,107.018 F1 · kind: The reported acquisition was pursuant to a broker maintained dividend reinvestment plan. Read SEC document |
| June 24, 2016 Filed Jan 9, 2017 21:00 UTC |
PACKER RICHARD ADirector
|
OtherCommon stock | 29.907 | $24.11 | $721.06 |
DisclosureSEC source: 0001179110-17-000745 · edgar.xml · nonDerivative · entry 2 PACKER RICHARD A · CIK 0001237765 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,056.098 F1 · kind: The reported acquisition was pursuant to a broker maintained dividend reinvestment plan. Read SEC document |
| March 24, 2016 Filed Jan 9, 2017 21:00 UTC |
PACKER RICHARD ADirector
|
OtherCommon Stock | 26.191 | $27.49 | $719.99 |
DisclosureSEC source: 0001179110-17-000745 · edgar.xml · nonDerivative · entry 1 PACKER RICHARD A · CIK 0001237765 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,026.191 F1 · kind: The reported acquisition was pursuant to a broker maintained dividend reinvestment plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.